【Diamond BioFund】Announcement of changes in shareholding and fair value of all investment targets, along with the company's net asset value per share, cash and cash equivalents balance
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Diamond Biotech Investment has announced its monthly changes in shareholdings and fair values of all investment targets as of April 2026, along with its net asset value per share and cash/cash equivalents balance. This disclosure is in compliance with Taiwan Stock Exchange regulations.